Zacks Investment Research provided stock analysis and ratings for Cencora on September 1, 2025.
2 reports, 1 independent
Updated Sep 1
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Zacks Investment Research provided stock analysis and ratings for Cencora on September 1, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Keep exploring
The entities involved
-
Cencora
US drug wholesale company company
Related events
Coverage
Newest first; wire copies grouped- ZacksHere's Why Cencora (COR) is a Strong Value Stock Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. While you may have an invest
- ZacksWhy This 1 Growth Stock Could Be a Great Addition to Your Portfolio For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may